Published in Antimicrob Agents Chemother on August 01, 1997
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med (2000) 5.08
Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol (2012) 1.69
Effect of parenteral fluoroquinolone administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. Antimicrob Agents Chemother (2004) 0.82
Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers. Antimicrob Agents Chemother (2001) 0.75
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother (1984) 3.35
Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans. Arzneimittelforschung (1986) 1.75
Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrob Agents Chemother (1989) 1.74
Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg (1991) 1.61
Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. J Infect Dis (1985) 1.45
Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay. Arzneimittelforschung (1987) 1.42
The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin. Pharmacotherapy (1989) 1.32
Norfloxacin binds to human fecal material. Antimicrob Agents Chemother (1988) 1.25
The intestinal elimination of ciprofloxacin in the rat. J Infect Dis (1994) 1.23
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob Agents Chemother (1986) 1.20
Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy (1988) 1.19
Sensitive and selective determination of picogram amounts of ciprofloxacin and its metabolites in biological samples using high-performance liquid chromatography and photothermal post-column derivatization. J Chromatogr (1987) 1.19
Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway? J Pharmacol Exp Ther (1994) 1.16
Sucralfate significantly reduces ciprofloxacin concentrations in serum. Antimicrob Agents Chemother (1990) 1.15
Inactivation of quinolone by feces. J Infect Dis (1986) 1.14
Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Clin Pharmacol Ther (1995) 1.05
An overview of the pharmacology of intravenously administered ciprofloxacin. Am J Med (1987) 0.97
Intestinal elimination of ciprofloxacin in rabbits. Antimicrob Agents Chemother (1994) 0.92
Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers. J Antimicrob Chemother (1990) 0.92
Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteers. Antimicrob Agents Chemother (1992) 0.90
Intestinal elimination of sparfloxacin, fleroxacin, and ciprofloxacin in rats. Antimicrob Agents Chemother (1995) 0.89
Pulmonary functional impairment from years of arc welding. Am J Med (1989) 0.88
Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis. Ann Intern Med (1989) 0.88
Effect of oral ciprofloxacin on the faecal flora of healthy volunteers. Eur J Clin Microbiol (1986) 0.87
Transintestinal elimination of ciprofloxacin. Diagn Microbiol Infect Dis (1990) 0.87
Effect of sucralfate on absorption of norfloxacin and ofloxacin. Antimicrob Agents Chemother (1994) 0.87
The mode of action of sucralfate: the 1 x 1 x 1 mechanism of action. Scand J Gastroenterol Suppl (1991) 0.86
Q fever in Spain: acute and chronic cases, 1981-1985. Rev Infect Dis (1988) 0.86
Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid. Eur J Clin Microbiol (1987) 0.84
The protective and therapeutic mechanisms of sucralfate. Scand J Gastroenterol Suppl (1990) 0.79
Ciprofloxacin prior to colon surgery. Diagn Microbiol Infect Dis (1990) 0.78
Ciprofloxacin levels when receiving sucralfate. JAMA (1989) 0.78
Transintestinal elimination of ciprofloxacin in humans--concomitant assessment of its metabolites in serum, ileum and colon. Infection (1993) 0.77
In vitro antibacterial activity of sucralfate. Eur J Clin Microbiol Infect Dis (1994) 0.77
Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood (1990) 2.42
PCR and blood culture for detection of Escherichia coli bacteremia in rats. J Clin Microbiol (1999) 2.28
Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med (2001) 2.27
[On demonstration of E. coli O 91 in dyspepsia]. Zentralbl Bakteriol Orig (1966) 2.20
Certain batches of albumin solutions influence the expression of endothelial cell adhesion molecules. Intensive Care Med (1999) 2.06
[Antibiotic effects of mixtures of polymethlmethacrylate with antibiotics]. Arch Orthop Unfallchir (1970) 1.68
Effects of pentachlorophenol and some of its known and possible metabolites on fungi. Appl Environ Microbiol (1986) 1.58
[Preoperative evaluation and perioperative management of patients with increased cardiovascular risk]. Anaesthesist (2005) 1.50
Susceptibility of Legionella spp. to quinolone derivatives and related organic acids. Eur J Clin Microbiol (1984) 1.42
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study. Eur J Gastroenterol Hepatol (1996) 1.40
Legionella infection of the colon presenting as acute attack of ulcerative colitis. Gastroenterology (1989) 1.40
Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med (1987) 1.31
Effects of regional anesthesia on phantom limb pain are mirrored in changes in cortical reorganization. J Neurosci (1997) 1.29
Polymerase chain reaction versus culture for detection of Ureaplasma urealyticum and Mycoplasma hominis in the urogenital tract of adults and the respiratory tract of newborns. Eur J Clin Microbiol Infect Dis (1996) 1.29
Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD). Intensive Care Med (1997) 1.16
Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration. Antimicrob Agents Chemother (1998) 1.15
[Isolation of penicillinase forming gonococci in Munich]. MMW Munch Med Wochenschr (1978) 1.07
Membrane proteins of legionellaceae. I. Membrane proteins of different strains and serogroups of Legionella pneumophila. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 1.05
Indirect immunofluorescence assay (IFA), microagglutination test (MA) and enzyme-linked-immunosorbent assay (ELISA) in diagnosis of legionellosis. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.03
A four-year review of fatal Aspergillosis. Eur J Clin Microbiol Infect Dis (1999) 1.03
Species specific membrane proteins of Legionellaceae. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.03
The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg (1997) 1.02
Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis (1996) 1.01
Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy (1990) 1.01
Microvascular changes during the early phase of experimental bacterial meningitis. J Cereb Blood Flow Metab (1990) 0.95
Nosocomial septicemia in patients undergoing sclerotherapy for variceal hemorrhage. Endoscopy (1984) 0.95
Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study. J Antimicrob Chemother (1983) 0.95
Beneficial effect of liposome-encapsulated muramyl tripeptide in experimental septicemia in a porcine model. Infect Immun (1991) 0.95
Postmortem analysis of invasive aspergillosis in a tertiary care hospital. Eur J Clin Microbiol Infect Dis (1997) 0.94
Methicillin-resistant Staphylococcus haemolyticus on the hands of health care workers: a route of transmission or a source? J Hosp Infect (1995) 0.93
Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics. Eur J Clin Microbiol (1984) 0.93
Influence of underlying disease on the outcome of critically ill patients with acute renal failure. Eur J Anaesthesiol (2004) 0.92
[Water-electrolyte balance and kidney function for 3 weeks following severe trauma]. Anasth Intensivther Notfallmed (1988) 0.92
Effects of pentachloronitrobenzene and some of its known and possible metabolites on fungi. Appl Environ Microbiol (1983) 0.91
Significance of non-pneumophila Legionella species in adult community-acquired and nosocomial pneumonias. Klin Wochenschr (1987) 0.91
Bacteriaemia associated with endoscopic sclerotherapy of oesophageal varices. Endoscopy (1985) 0.90
Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin. Scand J Gastroenterol Suppl (1993) 0.89
Discrimination between clinical and environmental strains of Legionella pneumophila by a monoclonal antibody. Isr J Med Sci (1986) 0.87
Spinal epidural abscess--a rare complication after epidural analgesia for labour and delivery. Br J Anaesth (2004) 0.86
Effect of catalase on regional cerebral blood flow and brain edema during the early phase of experimental pneumococcal meningitis. J Infect Dis (1992) 0.85
Identification of clinical and environmental isolates of Legionella pneumophila by analysis of outer-membrane proteins, ubiquinones and fatty acids. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.85
Risk factors for systemic fungal infections in liver transplant recipients. Eur J Clin Microbiol Infect Dis (1995) 0.85
Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in health subjects? Am J Clin Nutr (1994) 0.84
[Clostridium difficile and antibiotic-associated colitis in risk patients: 2-month epidemiologic study in an intensive care unit]. Klin Wochenschr (1983) 0.84
Steroid-induced invasive aspergillosis with thyroid gland abscess and positive blood cultures. Eur J Clin Microbiol Infect Dis (1998) 0.84
Effect of comprehensive validation of the template isolation procedure on the reliability of bacteraemia detection by a 16S rRNA gene PCR. Clin Microbiol Infect (2004) 0.83
The effect of human serum DNAases on the ability to detect antibiotic-killed Escherichia coli in blood by PCR. J Med Microbiol (2001) 0.83
Computer-aided densitometric analysis of protein patterns of Clostridium difficile. Eur J Clin Microbiol Infect Dis (1988) 0.83
Small intestinal transit, bacterial growth, and bowel habits in diabetes mellitus. Pancreas (1989) 0.83
[Patient safety and errors in medicine: development, prevention and analyses of incidents]. Anasthesiol Intensivmed Notfallmed Schmerzther (2001) 0.83
Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin. Am J Med (1989) 0.83
Peritonitis due to Mycoplasma hominis and Ureaplasma urealyticum in a liver transplant recipient. Eur J Clin Microbiol Infect Dis (1991) 0.83
Small intestinal myoelectrical activity and bacterial flora after Roux-en-Y reconstruction. Br J Surg (1996) 0.83
Influence of the pH-value on the growth of Staphylococcus epidermidis, Staphylococcus aureus and Propionibacterium acnes in continuous culture. Zentralbl Hyg Umweltmed (1992) 0.83
Patient data management systems in critical care. J Am Soc Nephrol (2001) 0.83
Distribution of auxotypes and correlation to antibiotic susceptibility of 169 recent clinical Neisseria gonorrhoeae isolates from Munich. Arch Dermatol Res (1983) 0.82
Imaging of leukocyte-endothelium interaction using in vivo confocal laser scanning microscopy during the early phase of experimental pneumococcal meningitis. J Infect Dis (1993) 0.81
[Comparative studies of the antibacterial effect of so-called basic cephalosporins]. Med Klin (Munich) (1988) 0.81
Evaluation of commercial kits for quantitative identification and tests on antibiotic susceptibility of genital mycoplasmas. Zentralbl Bakteriol (1996) 0.80
Lack of antimicrobial effect on periodontopathic bacteria by ultrasonic and sonic scalers in vitro. J Clin Periodontol (2000) 0.80
Enzyme immunoassay for detection of antibodies against isolated flagella of Legionella pneumophila. Eur J Clin Microbiol Infect Dis (1995) 0.80
Investigations on pivampicillin treatment in newborns and infants. Infection (1973) 0.80
Lung tissue concentrations of ciprofloxacin following intravenous administration in patients. Arzneimittelforschung (1989) 0.79
Susceptibility of Neisseria gonorrhoeae to cefotaxime: in vitro studies and treatment results. Arch Dermatol Res (1982) 0.79
Molecular weight of the major outer membrane protein of Legionella pneumophila. Eur J Clin Microbiol (1985) 0.79
Septicemia caused by Kingella kingae. Eur J Clin Microbiol (1984) 0.78
Detection by PCR of human polyomaviruses BK and JC in immunocompromised individuals and partial sequencing of control regions. J Med Virol (1994) 0.78
Bacterial overgrowth in ileal reservoirs (Koch pouch): extended functional studies. Hepatogastroenterology (1980) 0.78
[Community-acquired pneumonia]. Dtsch Med Wochenschr (1989) 0.78
[Noninvasive determination of cardiac output in ventilated patients . Clinical evaluation of a simplified quick method]. Anaesthesist (2003) 0.78
Febrile illness in successive cohorts of tourists at a hotel on the Italian Adriatic coast: evidence for a persistent focus of Legionella infection. Am J Epidemiol (1984) 0.77
Benzylamines: synthesis and evaluation of antimycobacterial properties. J Med Chem (1984) 0.77
[Perioperative echocardiography: basic principles]. Anaesthesist (2006) 0.77
[Comparative study on the value of selective decontamination of the digestive tract in acute leukemia patients (author's transl)]. Klin Wochenschr (1981) 0.76
Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia. Br J Anaesth (2012) 0.76
Elimination of meropenem by continuous hemo(dia) filtration: an in vitro one-compartment model. Int J Artif Organs (1999) 0.76
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH)--treatment with lithium. Intensive Care Med (1982) 0.76
[Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin]. Immun Infekt (1986) 0.76
[The GABA(A) receptor family: possibilities for the development of better anesthetics]. Anaesthesist (2006) 0.76
[Volume replacement in intensive care medicine]. Anaesthesist (2011) 0.76
Splenectomy does not influence outcome of pneumococcal septicemia in a porcine model. J Trauma (1991) 0.76
Mycoplasma hominis in liver transplantation. Surgery (1993) 0.75
[Quantitative in-vitro studies on the problem of gentamycin release from polymethyl methacrylate blocks]. Arch Orthop Unfallchir (1973) 0.75
Legionella infection in ulcerative colitis. Gastroenterology (1990) 0.75
[Germ mutation in internal medicine]. Internist (Berl) (1977) 0.75
[Legionnaires' disease in Munich. Case report and outline of the clinical picture (author's transl)]. MMW Munch Med Wochenschr (1979) 0.75
[Antimycobacterial effect of N-alkylbenzylamines]. Pharmazie (1977) 0.75
[Influence of formula diets on the intestinal flora]. MMW Munch Med Wochenschr (1976) 0.75
[Advising the expecting mother on the use of epidural anaesthetics in obstetrics]. Anaesthesist (2002) 0.75
[Infection caused by Vibrio fetus]. Munch Med Wochenschr (1973) 0.75
[Effects of formula diet with varying carbohydrate proportion on gut microflora in man]. Nutr Metab (1975) 0.75
[Legionnaires' disease in Germany (author's transl)]. Infection (1979) 0.75
[The relationship between structure and tuberculostatic effect in the benzylamine group]. Pharmazie (1976) 0.75
[E. coli serotype 078:K80 (B):H--in a green iguana (Iguana iguana L.)]. Zentralbl Veterinarmed B (1971) 0.75
[Proceedings: Choline derivatives in acute diarrheal diseases]. Fortschr Med (1975) 0.75